-transparent.png){kind=logo}
We have investigated the effect of glucose on the release of endothelin-1-like immunoreactivity (ET-1-LI) from cultured bovine aortic endothelial cells. Elevation of glucose concentrations in cultured media from 5.5 to 11.1 or 22.2 mM significantly stimulated ET-1-LI release from cultured endothelial cells. An aldose reductase inhibitor did not affect the high glucose-induced ET-1-LI release. These findings suggest the possibility that hyperglycemia in diabetic patients enhances ET-1-LI release at the local site of vascular endothelium, which might be involved in the developments of vascular complications and atherosclerosis.
Related Publications
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
March 1994,
The Journal of clinical investigation,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
August 1992,
The Journal of biological chemistry,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
January 1989,
Metabolism: clinical and experimental,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
May 1991,
Biochemical and biophysical research communications,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
June 1991,
Journal of molecular and cellular cardiology,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
January 1995,
Journal of cardiovascular pharmacology,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
February 1991,
Metabolism: clinical and experimental,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
August 2005,
Bioscience, biotechnology, and biochemistry,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
June 1995,
Journal of cardiovascular risk,
T Yamauchi, and
K Ohnaka, and
R Takayanagi, and
F Umeda, and
H Nawata
January 1996,
Life sciences,
